Thromboembolic and bleeding risk in cardiac amyloidosis

ISTH Academy, Faculty / Presenters, 4145697

Issue Information

ISTH Academy, Faculty / Presenters, 4145696

Acquired Hemophilia A: Emicizumab as Treatment?

ISTH Academy, Faculty / Presenters, 4144037

Publication Only Abstracts

ISTH Academy, Faculty / Presenters, 4149980

Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism

ISTH Academy, Faculty / Presenters, 4142482

Poster Abstracts

ISTH Academy, Faculty / Presenters, 4149979

Oral Communication Abstracts

ISTH Academy, Faculty / Presenters, 4149978

Late-breakthrough Abstracts

ISTH Academy, Faculty / Presenters, 4149977

Erratum to ‘Performance of Risk Scores in Predicting Major Bleeding in Left Ventricular Assist Device (LVAD) Recipients: a Comparative External Validation. ’[Res Pract Thromb Haemost. 2024;8:e102437]

ISTH Academy, Faculty / Presenters, 4147749

Letter in response to Bounaix et al. “Management of anticoagulation and factor XIII replacement in a patient with severe factor XIII deficiency and recurrent venous thromboembolic disease: case report and review of literature”

ISTH Academy, , 4147748

Cross-reacting antiporcine factor VIII inhibitors in patients with acquired hemophilia A

ISTH Academy, , 4147747

Fibrinolytic profile depends on disease severity in pediatric patients with cirrhosis: illustration by 2 different plasma-based fibrinolysis assays

ISTH Academy, Faculty / Presenters, 4147746

Evaluation of hemostasis understanding in medical and pharmacy students from a Parisian university

ISTH Academy, , 4147745

Physician practice patterns on the use of inferior vena cava filters in venous thromboembolism

ISTH Academy, , 4147744

Methods of a cluster-randomized, type II hybrid implementation effectiveness trial to prospectively assess extended-duration thromboprophylaxis for at-risk medical patients being discharged to prevent hospital-associated venous thromboembolism

ISTH Academy, , 4147743

LAIR-1 and PECAM-1 function via the same signaling pathway to inhibit GPVI-mediated platelet activation

ISTH Academy, Alexandra Mazharian, 4147742

G protein–coupled receptor kinase 5 regulates thrombin signaling in platelets

ISTH Academy, Craig Morrell, 4147741

Dual direct oral anticoagulant therapy in challenging thrombosis: a case series

ISTH Academy, Agnes Lee, 4147740

Is lupus anticoagulant testing with dilute Russell’s viper venom clotting times reliable in the presence of inflammation?

ISTH Academy, Faculty / Presenters, 4147739

Predictors of diagnostic delays and loss to follow-up in women with von Willebrand disease: a single-center retrospective cohort study

ISTH Academy, , 4147738

Issue Information

ISTH Academy, Faculty / Presenters, 4142467

RNA therapeutics to control fibrinolysis: review on applications in biology and medicine

ISTH Academy, Christian Kastrup, 4142468

Application of genetic testing for the diagnosis of von Willebrand disease

ISTH Academy, Flora Peyvandi, 4142469

Thrombotic risk associated with gender-affirming hormone therapy

ISTH Academy, , 4142470

The convergent model of coagulation

ISTH Academy, Cheng Hock Toh, 4142471

Unexpected bleeding with platelet phosphatidylserine exposure defect: new kindred motivates rethinking Scott syndrome

ISTH Academy, Gary Gilbert, 4142472

Venous thromboembolism and estrogen—dance with the devil in thrombosis medicine

ISTH Academy, Marc Carrier, 4142473

Mimicking activated protein C-progress by PARtnering peptides

ISTH Academy, Roger Preston, 4142474

Dilemmas in the diagnosis and management of antiphospholipid syndrome

ISTH Academy, Deepa Arachchillage, 4142475

DNA base editing corrects common hemophilia A mutations and restores factor VIII expression in in vitro and ex vivo models

ISTH Academy, Faculty / Presenters, 4142476

The historical origins of modern international normalized ratio targets

ISTH Academy, Faculty / Presenters, 4142477

Hormonal contraceptive use after a first venous thrombotic event and the risk of recurrence in premenopausal women

ISTH Academy, Astrid van Hylckama Vlieg, 4142478

Diagnosis of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: data from a practice-based longitudinal cohort

ISTH Academy, Faculty / Presenters, 4142479

Minimally modified human blood coagulation factor X to bypass direct factor Xa inhibitors

ISTH Academy, Mettine Bos, 4142480

Perioperative management and outcomes in patients receiving low-dose rivaroxaban and/or aspirin: a subanalysis of the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) trial

ISTH Academy, Faculty / Presenters, 4142481

How to undertake procedures while on antiplatelet agents: a hematologist's view

ISTH Academy, Jecko Thachil, 4147723

Fibrinogen binding to histones in circulation protects against adverse cellular and clinical outcomes

ISTH Academy, Cheng-Hock Toh, 4142483

Genome-wide investigation of exogenous female hormones, genetic variation, and venous thromboembolism risk

ISTH Academy, Nicholas Smith, 4142484

Met343Val mutation disrupts the shuttling of Trp380 leading to a low-activity conformer of activated protein C and causes thrombosis

ISTH Academy, Yeling Lu, 4142485

Comprehensive functional characterization of a novel ANO6 variant in a new patient with Scott syndrome

ISTH Academy, Neil Morgan, 4142486

Acidification of α-granules in megakaryocytes by vacuolar-type adenosine triphosphatase is essential for organelle biogenesis

ISTH Academy, Walter Kahr, 4142487

The use of 1E12, a monoclonal anti-platelet factor 4 antibody, to improve the diagnosis of vaccine-induced immune thrombotic thrombocytopenia

ISTH Academy, Faculty / Presenters, 4142488

Extracorporeal membrane oxygenation aggravates platelet glycoprotein V shedding and δ-granule deficiency in COVID-19–associated acute respiratory distress syndrome

ISTH Academy, Harald Schulze, 4142489

Development of endothelial-targeted CD39 as a therapy for ischemic stroke

ISTH Academy, Maithili Sashindranath, 4142490

Toward harmonized interpretation of anticardiolipin and anti–β2-glycoprotein I antibody detection for diagnosis of antiphospholipid syndrome using defined level intervals and likelihood ratios: communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies

ISTH Academy, Katrien Devreese, 4142491

“Prothrombin conversion and thrombin decay in patients with cirrhosis—role of prothrombin and antithrombin deficiencies”: comment from de Laat-Kremers et al.

ISTH Academy, Faculty / Presenters, 4142492

“Prothrombin conversion and thrombin decay in patients with cirrhosis—role of prothrombin and antithrombin deficiencies”: comment

ISTH Academy, Thomas Lecompte, 4142493

“Antiphospholipid antibody solid phase–based assays: problems and proposed solutions for the 2023 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for antiphospholipid syndrome”: comment

ISTH Academy, Armando Tripodi, 4142494

“Antiphospholipid antibody solid phase–based assays: problems and proposed solutions for the 2023 ACR/EULAR classification criteria for antiphospholipid syndrome”: reply

ISTH Academy, Faculty / Presenters, 4142495

Obituary Professor Margareta “Meta” Blombäck (1925-2024)

ISTH Academy, Faculty / Presenters, 4142496

Platelet reactivity is associated with pump thrombosis in patients with left ventricular assist devices

ISTH Academy, , 4147737

Annoucements

ISTH Academy, Faculty / Presenters, 4142498

Proportion and risk factors for hospital-acquired venous thromboembolism in children: a systematic review and meta-analysis of data from 20 million individuals in 22 countries

ISTH Academy, Jinhua Zhang, 4147736

A single-center study of patients with rare isolated acquired clotting factor deficiencies other than acquired hemophilia A

ISTH Academy, Lei Zhang, 4147735

Corrigendum to ‘Trivalent nanobody-based ligands mediate powerful activation of GPVI, CLEC-2 and PEAR1 in human platelets whereas FcγRIIA requires a tetravalent ligand’

ISTH Academy, Steve Watson, 4142497

Plant-derived compounds normalize platelet bioenergetics and function in hyperglycemia

ISTH Academy, , 4147734

Oxidative stress–induced fibrinogen modifications in liver transplant recipients: unraveling a novel potential mechanism for cardiovascular risk

ISTH Academy, Faculty / Presenters, 4147733

Antipolyphosphate monoclonal antibodies derived from autoimmune mice

ISTH Academy, James Morrissey, 4147732

Traumatic bleeding and mortality in mice are intensified by iron deficiency anemia and can be rescued with tranexamic acid

ISTH Academy, Faculty / Presenters, 4147731

Intensive care treatment in acute pulmonary embolism in Germany, 2016 to 2020: a nationwide inpatient database study

ISTH Academy, Faculty / Presenters, 4147730

Prescription and switching patterns of direct oral anticoagulants in patients with atrial fibrillation

ISTH Academy, Faculty / Presenters, 4147729

Pharmacokinetics and pharmacodynamics of low doses of recombinant tissue plasminogen activator to establish a model for biosimilarity comparisons

ISTH Academy, Faculty / Presenters, 4147728

Can hemophilia be cured? It depends on the definition

ISTH Academy, , 4147727

The risk of venous thromboembolism in primary central nervous system lymphoma: a systematic review and meta-analysis

ISTH Academy, , 4147726

MYH9-related inherited thrombocytopenia: the genetic spectrum, underlying mechanisms, clinical phenotypes, diagnosis, and management approaches

ISTH Academy, , 4147725

Comprehensive literature review of protein C concentrate use in patients with severe congenital protein C deficiency

ISTH Academy, Faculty / Presenters, 4147724

New Insights in Diagnosis and Treatment of Antiphospholipid Syndrome

ISTH Academy, Faculty / Presenters, 4139869

Integrating musculoskeletal ultrasound as a shared decision-making tool in hemophilia care: observations from a 3-year study

ISTH Academy, Faculty / Presenters, 4145776

Excessive cleavage of von Willebrand factor multimers by ADAMTS13 may predict the progression of transplant-associated thrombotic microangiopathy

ISTH Academy, Masanori Matsumoto, 4145785

The association between unemployment and treatment among adults with hemophilia

ISTH Academy, Faculty / Presenters, 4145775

Primary postpartum hemorrhage in women with von Willebrand disease and carriers of hemophilia: a retrospective analysis

ISTH Academy, Faculty / Presenters, 4145774

Safety and efficacy of anticoagulant treatment in patients with ovarian vein thrombosis: a systematic review and meta-analysis of observational studies

ISTH Academy, , 4145773

Modeling cancer-associated hypercoagulability using glioblastoma spheroids in microfluidic chips

ISTH Academy, Araci Rondon, 4145772

Real-world usage and effectiveness of recombinant factor VIII/factor IX Fc in hemophilia A/B: final data from the 24-month, prospective, noninterventional PREVENT study in Germany

ISTH Academy, Faculty / Presenters, 4145771

Interference of lupus anticoagulant causing antiprothrombin and anti–beta-2-glycoprotein I antibodies on international normalized ratio measurements: comparative analysis of international normalized ratio methods

ISTH Academy, Faculty / Presenters, 4145770

Thromboembolic events in severe postpartum hemorrhage treated with recombinant activated factor VII: a systematic literature review and meta-analysis

ISTH Academy, Faculty / Presenters, 4145769

Quality of life in oncological patients with venous thromboembolic disease

ISTH Academy, Cristhiam Mauricio Rojas Hernandez, 4145768

Hemorrhage in acute promyelocytic leukemia—fibrinolysis in focus

ISTH Academy, , 4145767

Syndemics in women’s health: poverty, social exclusion, and clustering of thrombotic and hemostasis disorders

ISTH Academy, , 4145766

Bleeding in valvular heart disease: is von Willebrand factor the culprit?

ISTH Academy, Sophie Susen, 4145765

Navigating the inevitable: artificial intelligence and the future of scientific communication

ISTH Academy, , 4145764

Issue Information

ISTH Academy, Faculty / Presenters, 4140557

Management of abnormal uterine bleeding on anticoagulation: the patient–clinician perspective

ISTH Academy, Bethany Samuelson Bannow, 4140560

Recent advances in vascular thiol isomerases and redox systems in platelet function and thrombosis

ISTH Academy, Faculty / Presenters, 4140559

Biomarkers of bleeding and venous thromboembolism in patients with acute leukemia

ISTH Academy, Radhika Gangaraju, 4140577

Unmet needs and barriers in venous thromboembolism education and awareness among people living with cancer: a global survey

ISTH Academy, Faculty / Presenters, 4140576

Microtubule interacting and trafficking domain containing 1 deficiency leads to poor survival via tissue factor-mediated coagulation in bladder cancer

ISTH Academy, , 4140575

Disparities in access to and timing of interventional therapies for pulmonary embolism across the United States

ISTH Academy, Faculty / Presenters, 4140574

Diagnosis of thrombotic thrombocytopenic purpura: easy-to-use fiber optic surface plasmon resonance immunoassays for automated ADAMTS-13 antigen and conformation evaluation

ISTH Academy, Karen Vanhoorelbeke, 4140573

Role of microbiota-derived corisin in coagulation activation during SARS-CoV-2 infection

ISTH Academy, Faculty / Presenters, 4140572

Application of machine learning approaches for predicting hemophilia A severity

ISTH Academy, Zuben Sauna, 4140571

Variant mapping using mass spectrometry–based proteotyping as a diagnostic tool in von Willebrand disease

ISTH Academy, Maartje van den Biggelaar, 4140570

Three-year outcomes of valoctocogene roxaparvovec gene therapy for hemophilia A

ISTH Academy, Faculty / Presenters, 4140569

The effect of administering preprocedural VITamin K on the international normalized ratio in patients anticoagulated with ACEnocoumarol (VITKACE-study): a prospective cohort study

ISTH Academy, Remy Bemelmans, 4140566

Ultra-Long factor VIII: a major step forward toward a hemophilia-free mind

ISTH Academy, Faculty / Presenters, 4140565

Time to simplify perioperative management of vitamin K antagonists

ISTH Academy, Daniel Witt, 4140564

A hard look in the mirror: disparities in reperfusion therapy for acute pulmonary embolism in the United States and failure to reduce mortality

ISTH Academy, Gregory Piazza, 4140563

Microbiota-driven coagulation activation during SARS-CoV-2 infection

ISTH Academy, Silvio Antoniak, 4140562

Next-generation sequencing strategies in venous thromboembolism: in whom and for what purpose?

ISTH Academy, Faculty / Presenters, 4140561

Removing cross-cultural barriers to participation in the ISTH Congress

ISTH Academy, Alan Harper, 4140558